These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23161260)

  • 1. Understanding quantitative and qualitative figural fluency in patients with Parkinson's disease.
    Goebel S; Atanassov L; Köhnken G; Mehdorn HM; Leplow B
    Neurol Sci; 2013 Aug; 34(8):1383-90. PubMed ID: 23161260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measures of figural fluency: Relationship to neuropsychological variables and traumatic brain injury severity.
    Ladowsky-Brooks RL; Chan A
    Appl Neuropsychol Adult; 2022; 29(4):551-561. PubMed ID: 32649850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semantic and phonemic verbal fluency in Parkinson's disease: Influence of clinical and demographic variables.
    Obeso I; Casabona E; Bringas ML; Alvarez L; Jahanshahi M
    Behav Neurol; 2012; 25(2):111-8. PubMed ID: 22530265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive or Cognitive-Motor Executive Function Tasks? Evaluating Verbal Fluency Measures in People with Parkinson's Disease.
    Barbosa AF; Voos MC; Chen J; Francato DCV; Souza CO; Barbosa ER; Chien HF; Mansur LL
    Biomed Res Int; 2017; 2017():7893975. PubMed ID: 28904971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Cognitive Impairment in Parkinson's Disease: Clustering and Switching Analyses in Verbal Fluency Test.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Int Neuropsychol Soc; 2017 Jul; 23(6):511-520. PubMed ID: 28494819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced verbal fluency for proper names in nondemented patients with Parkinson's disease: a quantitative and qualitative analysis.
    Fine EM; Delis DC; Paul BM; Filoteo JV
    J Clin Exp Neuropsychol; 2011 Feb; 33(2):226-33. PubMed ID: 20936559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of executive functions in patients with Parkinson's disease using the new rapid test PAL-5].
    Scheffels JF; Engels JE; Kalbe E; Kessler J
    Fortschr Neurol Psychiatr; 2018 Apr; 86(4):219-225. PubMed ID: 29186725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairments associated with early Parkinson's disease.
    Levin BE; Llabre MM; Weiner WJ
    Neurology; 1989 Apr; 39(4):557-61. PubMed ID: 2927680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Indices of Clustering and Switching of Semantic Verbal Fluency in Parkinson's Disease.
    Farzanfar D; Statucka M; Cohn M
    J Int Neuropsychol Soc; 2018 Nov; 24(10):1047-1056. PubMed ID: 30282568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is measured with verbal fluency tests in Parkinson's disease patients at different stages of the disease?
    Koerts J; Meijer HA; Colman KS; Tucha L; Lange KW; Tucha O
    J Neural Transm (Vienna); 2013 Mar; 120(3):403-11. PubMed ID: 22922998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Parkinson's disease subgroups on verbal and nonverbal fluency.
    Jaywant A; Musto G; Neargarder S; Stavitsky Gilbert K; Cronin-Golomb A
    J Clin Exp Neuropsychol; 2014; 36(3):278-89. PubMed ID: 24533593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
    J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action verbal fluency in Parkinson's patients.
    Rodrigues IT; Ferreira JJ; Coelho M; Rosa MM; Castro-Caldas A
    Arq Neuropsiquiatr; 2015 Jun; 73(6):520-5. PubMed ID: 26083889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential patterns of internally generated responses in parkinsonian disorders.
    Tjokrowijoto P; Ceslis A; Sullivan JDO; Adam R; Mellick G; Silburn P; Robinson GA
    Neuropsychologia; 2020 Sep; 146():107569. PubMed ID: 32707163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
    Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action fluency in Parkinson's disease: a follow-up study.
    Signorini M; Volpato C
    Mov Disord; 2006 Apr; 21(4):467-72. PubMed ID: 16250017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.